Results 211 to 220 of about 28,989 (238)
Some of the next articles are maybe not open access.
Pathogenesis of transthyretin amyloidosis
Amyloid, 2012Current dogma for transthyretin (TTR) pathogenesis is that mutations in TTR alter its structure such that the tetramer becomes unstable and prone to release of monomer which then becomes the putative building block of the fibril. This hypothesis is supported by thermodynamic data showing decreased stability of mutant TTR tetrameric proteins and ...
openaire +2 more sources
Hereditäre Transthyretin-Amyloidosen
Der Nervenarzt, 2014Hereditary amyloidosis is an autosomal dominant fatal multisystem disease caused by extracellular deposition of misfolded proteins and, therefore represents a hereditary protein folding or deposition disease that leads to progressive organ damage and eventually death.
openaire +2 more sources
Transthyretin amyloid cardiomyopathy
The American Journal of the Medical Sciences, 2023Giuseppe, Famularo, Guido, Ventroni
openaire +2 more sources
Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta‐analysis
European Journal of Heart Failure, 2022Alexios S Antonopoulos +2 more
exaly
Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma
Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2021Jin Xu, Bill Webb, Evan T Powers
exaly
Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy
Annals of Pharmacotherapy, 2020Hua Ling
exaly
Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2022
Felix Kleefeld +2 more
exaly
Felix Kleefeld +2 more
exaly
Transthyretin in bladder cancer
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020T, Lei, B, Gong, Q, Meng, M, Zhang
openaire +2 more sources